Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2  /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Wednesday, February 24, 2010 at 8:30 am EST to review results for the fourth quarter and full year ended December 31, 2009.  Par will release its financial results on February 24 before the market opens.

Access to the live webcast can be made via the Company's website at http://www.parpharm.com/.

          Dial-in Information
          -------------------
       Domestic:       866-770-7129
     International:    617-213-8067
       Passcode:           49930027




A replay of the conference call will be available for two weeks approximately one hour after the call.

           Replay Information
           ------------------
  Domestic:            866-286-8010
  International:       617-801-6888
  Passcode:                90488345



  About Par



Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit http://www.parpharm.com/. 

DATASOURCE: Par Pharmaceutical Companies, Inc.



CONTACT:  Allison Wey, Senior Director, Investor Relations and Corporate

Affairs, Par Pharmaceutical Companies, Inc., [phone]



Web Site:  http://www.parpharm.com/ 

Copyright